# Hydralazine

## Apresoline 50mg

##### 

| TAH Drug Code      | [OAPR5](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OAPR5)                                                                                                                                                                    |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Hypertension,為周邊血管擴張劑(A030879100)                                                                                                                                                                                                 |
| Dosing             | HTN Adult: 10-50 mg QID slowly titrate up (Maximum dose 300 mg/day). Child: 0.75 mg/kg/day in 4 divided doses, up to 7.5 mg/kg/day. (Maximum dose 300mg/day).                                                                             |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                             |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                             |
| Contraindications  | Idiopathic SLE & related diseases. Severe tachycardia & heart failure with high cardiac output. Myocardial insufficiency due to mechanical obstruction. Right ventricular heart failure due to pulmonary HTN. Dissecting aortic aneurysm. |
| Adverse Effects    | Tachycardia, palpitation, anginal symptoms, flushing, headache, dizziness, nasal congestion, GI disturbances.                                                                                                                             |
| Pregnancy          | Human Data Suggest Risk in 3Rd Trimester                                                                                                                                                                                                  |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                             |

